November 22, 2008FDA delays decision on Genzyme drug - Boston Globe FDA delays decision on Genzyme drug - Boston Globe
Genzyme Corp ., a Cambridge drug maker, said the US Food and Drug Administration has extended its deadline for reviewing Genzyme's application to market a new version of Myozyme, a drug for Pompe disease, manufactured at the company's Boston plant by Source: www.boston.com Now see this: Ohio boy gets prosthetic iris - Newark Advocate CINCINNATI (AP) — An Ohio boy born without irises is starting to see colors more clearly after receiving a prosthetic iris. Surgeons from the Cincinnati Eye Institute implanted the custom-made device Thursday into the right eye of 7-year-old Source: www.newarkadvocate.com US Food and Drug Administration to open China offices in effort to - Duluth News Tribune The U.S. Food and Drug Administration will open three offices in China this week in an unprecedented effort to improve the safety of exports headed to America amid recurring product safety scares. The new FDA offices, which are the first outside of Source: www.duluthnewstribune.com New mad cow rule poses dangers of its own - Dubuque Telegraph Herald LITITZ, Pa. (AP) -- A federal regulation aimed at preventing mad cow disease from getting into the food supply could create health risks of its own: many thousands of cattle carcasses rotting on farms, spreading germs, attracting vermin and polluting Source: www.thonline.com Wolters Kluwer Health Expands Tall Man Drug Name Lettering in Medi - Businesswire.com INDIANAPOLIS--( BUSINESS WIRE )--Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that its Medi-Span product line will significantly increase the number of “ Tall Man Source: www.businesswire.com # posted by Network @ 4:00 PM
 |
Subscribe to Posts [Atom]